Anne Gussow

Array ( [id] => 8214620 [patent_doc_number] => 08193316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'TACI-Fc fusion proteins, methods of making and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/638392 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10207 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193316.pdf [firstpage_image] =>[orig_patent_app_number] => 12638392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635067 [patent_doc_number] => 20100226854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'MHC Peptide Complexes and Uses Thereof in Infectious Diseases' [patent_app_type] => utility [patent_app_number] => 12/619039 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 77 [patent_figures_cnt] => 77 [patent_no_of_words] => 225802 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226854.pdf [firstpage_image] =>[orig_patent_app_number] => 12619039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685454 [patent_doc_number] => 20100120687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Modulating apoptosis' [patent_app_type] => utility [patent_app_number] => 12/617639 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17113 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120687.pdf [firstpage_image] =>[orig_patent_app_number] => 12617639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320465 [patent_doc_number] => 20100196364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2' [patent_app_type] => utility [patent_app_number] => 12/614282 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12661 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196364.pdf [firstpage_image] =>[orig_patent_app_number] => 12614282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289872 [patent_doc_number] => 20100158904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'TREATMENT WITH ANTI-ALPHA2 INTEGRIN ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/614178 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31147 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158904.pdf [firstpage_image] =>[orig_patent_app_number] => 12614178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7967065 [patent_doc_number] => 07939639 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology' [patent_app_type] => utility [patent_app_number] => 12/569821 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 76 [patent_no_of_words] => 20320 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939639.pdf [firstpage_image] =>[orig_patent_app_number] => 12569821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441554 [patent_doc_number] => 20100104574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Frizzled-Binding Agents and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/568534 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 52560 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104574.pdf [firstpage_image] =>[orig_patent_app_number] => 12568534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292583 [patent_doc_number] => 20100239581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'KIDNEY DISEASE TARGETS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/557303 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42789 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239581.pdf [firstpage_image] =>[orig_patent_app_number] => 12557303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588757 [patent_doc_number] => 20100061993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Antibodies' [patent_app_type] => utility [patent_app_number] => 12/585180 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 54608 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061993.pdf [firstpage_image] =>[orig_patent_app_number] => 12585180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6595657 [patent_doc_number] => 20100292085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Methods and compositions for characterization of HSD1 inhibitors' [patent_app_type] => utility [patent_app_number] => 12/584317 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28437 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292085.pdf [firstpage_image] =>[orig_patent_app_number] => 12584317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024852 [patent_doc_number] => 20110053178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Methods and Compositions for Detection of Lethal Cell and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/553035 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18047 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053178.pdf [firstpage_image] =>[orig_patent_app_number] => 12553035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465686 [patent_doc_number] => 20090325886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'WT1 MODIFIED PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/552660 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4290 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325886.pdf [firstpage_image] =>[orig_patent_app_number] => 12552660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8244770 [patent_doc_number] => 08202692 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Expression profile of thyroid cancer' [patent_app_type] => utility [patent_app_number] => 12/546278 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 35097 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202692.pdf [firstpage_image] =>[orig_patent_app_number] => 12546278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575349 [patent_doc_number] => 20100047166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'ANTIBODIES AND RELATED MOLECULES THAT BIND TO 58P1D12 PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/544973 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 67978 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047166.pdf [firstpage_image] =>[orig_patent_app_number] => 12544973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8445816 [patent_doc_number] => 08287864 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Structural variants of antibodies for improved therapeutic characteristics' [patent_app_type] => utility [patent_app_number] => 12/506996 [patent_app_country] => US [patent_app_date] => 2009-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 39590 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12506996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6543748 [patent_doc_number] => 20100016211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Treatment of Melanoma With Alpha Thymosin Peptides' [patent_app_type] => utility [patent_app_number] => 12/501829 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4787 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016211.pdf [firstpage_image] =>[orig_patent_app_number] => 12501829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576606 [patent_doc_number] => 20100047239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Dual variable domain immunoglobulin and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/459624 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 56838 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047239.pdf [firstpage_image] =>[orig_patent_app_number] => 12459624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6544035 [patent_doc_number] => 20100016228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'TRUNCATED BARD1 PROTEIN, AND ITS DIAGNOSTIC AND THERAPEUTIC USES' [patent_app_type] => utility [patent_app_number] => 12/489893 [patent_app_country] => US [patent_app_date] => 2009-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6212 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016228.pdf [firstpage_image] =>[orig_patent_app_number] => 12489893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6135099 [patent_doc_number] => 20110008840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'ANTI-CD33 ANTIBODIES AND METHODS FOR TREATMENT OF ACUTE MYELOID LEUKEMIA USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/483543 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 18373 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008840.pdf [firstpage_image] =>[orig_patent_app_number] => 12483543 [rel_patent_id] =>[rel_patent_doc_number] =>)